Ahrens Investment Partners LLC Bausch Health Companies Inc. Transaction History
Ahrens Investment Partners LLC
- $200 Million
- Q1 2023
A detailed history of Ahrens Investment Partners LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 205 shares of BHC stock, worth $932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205Holding current value
$932% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
243MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$158 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$138 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$120 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$106 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$59.2 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.65B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...